Novo Nordisk A/S NVO

$ 105.13 2.44%

Annual report 2023
added 11-16-2024

Novo Nordisk A/S Balance Sheet 2011-2024 | NVO

Annual Balance Sheet Novo Nordisk A/S

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-15.1 B	-17.2 B	-18.5 B	-15.8 B	-13.7 B	-10.5 B	-11.1 B	-12.6 B
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	502 M
Long Term Debt Current	1.17 B	986 M	822 M	775 M	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	11.3 B	9.04 B	4.77 B	5.48 B	4.83 B	3.96 B	3.08 B	3.54 B	3.4 B	6.47 B
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	208 B	158 B	124 B	81.6 B	68 B	58.9 B	52.5 B	52.3 B	44.8 B	36.8 B	27.8 B	25 B	27.2 B
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	63.8 B	57.8 B	53.4 B	49 B	46.1 B	46.8 B	41.3 B	41.1 B	39 B	37.1 B
Total Assets	314 B	241 B	195 B	145 B	126 B	111 B	102 B	97.5 B	91.8 B	77.1 B	70.3 B	65.7 B	64.7 B
Cash and Cash Equivalents	14.4 B	12.7 B	10.7 B	12.2 B	15.4 B	-	-	-	-	-	-	-	-
Book Value	107 B	83.5 B	70.7 B	63.3 B	57.6 B	51.8 B	49.8 B	45.3 B	47 B	40.3 B	42.6 B	40.6 B	37.4 B
Total Shareholders Equity	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in DKK currency

Quarterly Balance Sheet Novo Nordisk A/S

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	3.31 B	-	-	-	2.9 B	-	-	-	3.01 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	24.2 B	-	-	-	11.3 B	-	-	-	9.04 B	-	-	-	4.77 B	-	-	-	5.48 B	-	-	-	4.83 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	124 B	-	-	-	81.6 B	-	-	-	68 B	-	-	-	58.9 B	-	-	-	52.5 B	-	-	-	52.3 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	72 B	-	-	-	63.8 B	-	-	-	57.8 B	-	-	-	53.4 B	-	-	-	49 B	-	-	-	46.1 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	195 B	-	-	-	145 B	-	-	-	126 B	-	-	-	111 B	-	-	-	102 B	-	-	-	97.5 B	-	-	-	91.8 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	10.7 B	-	-	-	12.2 B	-	-	-	15.4 B	-	-	-	15.6 B	-	-	-	17.2 B	-	-	-	18.5 B	-	-	-	15.8 B	-	-	-	13.7 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	70.7 B	-	-	-	63.3 B	-	-	-	57.6 B	-	-	-	51.8 B	-	-	-	49.8 B	-	-	-	45.3 B	-	-	-	91.8 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	70.7 B	-	-	-	63.3 B	-	-	-	57.6 B	-	-	-	51.8 B	-	-	-	49.8 B	-	-	-	45.3 B	-	-	-	47 B	-	-	-	40.3 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in DKK currency